Skip to main content
Premium Trial:

Request an Annual Quote

Deborah Day Barbara, Sanjiv Sam Gambhir

Premium
Strategic Diagnostics said this week Deborah Day Barbara has joined the company as vice president of business development. Her employment became effective Oct. 13.
 
Barbara had been vice president of business development and licensing for Ore Pharmaceuticals. Before that she was senior director of business and technology development for Johns Hopkins University and spent 11 years at Amersham Life Sciences in various sales positions.
 

 
Sanjiv Sam Gambhir has been appointed to the US National Academies Institute of Medicine.
 
Gambhir is the scientific program director at the Canary Foundation where he leads a team of researchers in proteomics, genomics, epigenomics, and other fields. He is also a professor of radiology and bioengineering at Stanford University where he is chief of the nuclear medicine division and director of the Molecular Imaging Program.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.